Table 2.

Adherence measures for SPAA and CCB+statin primary prevention patients

	SPAA		CCB+Statin
	(N = 1,537)		(N = 17,910)		p-value
6 Months
Number (%) of patients with PDC ≥80%	868	56.5%	3,825	21.4%	<.001
Mean PDC (SD)	0.73	(0.26)	0.49	(0.31)
Median PDC	0.83		0.50		<.001
12 Months
Number (%) of patients with PDC ≥ 80%	712	46.3%	3,529	19.7%	<.001
Mean PDC (SD)	0.66	(0.30)	0.46	(0.31)
Median PDC	0.75		0.46		<.001
18 Months
Number (%) of patients with PDC ≥ 80%	650	42.3%	3,342	18.7%	<.001
Mean PDC (SD)	0.62	(0.31)	0.43	(0.32)
Median PDC	0.72		0.42		<.001